Apex Biotechnology Corp. (TPE:1733)

Apex Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	526.62	532.69	382.05	331.71	555.33	786.95
Trading Asset Securities	68.15	66.1	61.87	65.83	69.72	36.01
Cash & Short-Term Investments	594.77	598.78	443.91	397.53	625.05	822.96
Cash Growth	29.38%	34.89%	11.67%	-36.40%	-24.05%	2.48%
Accounts Receivable	446.93	346.64	288.39	486.77	474.41	325.41
Other Receivables	13.49	8.08	5.72	10.12	13.97	17.28
Receivables	460.42	354.72	294.11	496.89	488.38	342.68
Inventory	605.4	662.49	747.71	739.25	628.59	504.54
Prepaid Expenses	16.8	24.78	18.51	19	11.06	13.47
Other Current Assets	2.03	2.29	2.4	1.81	6.78	0.83
Total Current Assets	1,679	1,643	1,507	1,654	1,760	1,684
Property, Plant & Equipment	683.62	695.81	720.59	766.08	794.12	827.81
Other Intangible Assets	38.86	39.6	44.22	69.14	106.48	128.92
Long-Term Deferred Tax Assets	12.81	9.24	4.24	3.62	0.43	2.39
Other Long-Term Assets	29.17	32.23	21.32	21.38	9.58	7.86
Total Assets	2,444	2,420	2,297	2,515	2,670	2,651
Accounts Payable	224.7	239.03	156.22	289.69	343.89	245
Accrued Expenses	131.27	142.25	133.43	150.55	148.07	125.41
Short-Term Debt	-	-	30	50	150	-
Current Portion of Long-Term Debt	-	-	-	-	-	389.88
Current Portion of Leases	9.01	9.03	7.2	8.01	6.88	5.56
Current Income Taxes Payable	40.91	24.52	46.24	36.92	40.12	70.28
Current Unearned Revenue	28.88	58.28	6.6	29.04	93.06	42.61
Other Current Liabilities	126.07	4.68	3.67	6.35	3.87	4.7
Total Current Liabilities	560.84	477.78	383.35	570.55	785.89	883.43
Long-Term Leases	107.32	113.93	116.2	122.67	127.66	118.28
Long-Term Deferred Tax Liabilities	8.46	3.54	0.04	3.1	2.88	1.21
Other Long-Term Liabilities	0.48	0.47	0.48	0.49	0.48	0.48
Total Liabilities	677.09	595.7	500.07	696.81	916.91	1,005
Common Stock	999.5	999.5	999.5	999.5	999.5	999.5
Additional Paid-In Capital	68.37	68.37	68.37	68.37	68.37	66.78
Retained Earnings	686.14	744.06	718.87	739.95	682.34	586.9
Treasury Stock	-	-	-	-	-	-12.25
Comprehensive Income & Other	12.16	11.67	9.69	9.51	2.52	4.45
Total Common Equity	1,766	1,824	1,796	1,817	1,753	1,645
Minority Interest	0.61	0.63	0.5	0.57	0.82	0.78
Shareholders' Equity	1,767	1,824	1,797	1,818	1,754	1,646
Total Liabilities & Equity	2,444	2,420	2,297	2,515	2,670	2,651
Total Debt	116.33	122.96	153.4	180.68	284.55	513.72
Net Cash (Debt)	478.44	475.83	290.52	216.85	340.5	309.24
Net Cash Growth	41.99%	63.79%	33.97%	-36.31%	10.11%	61.63%
Net Cash Per Share	4.76	4.74	2.90	2.15	3.22	2.74
Filing Date Shares Outstanding	99.95	99.95	99.95	99.95	99.95	99.38
Total Common Shares Outstanding	99.95	99.95	99.95	99.95	99.95	99.38
Working Capital	1,119	1,165	1,123	1,084	973.97	801.05
Book Value Per Share	17.67	18.25	17.97	18.18	17.54	16.56
Tangible Book Value	1,727	1,784	1,752	1,748	1,646	1,516
Tangible Book Value Per Share	17.28	17.85	17.53	17.49	16.47	15.26
Land	261.68	261.68	261.68	261.68	261.68	261.68
Buildings	605.02	605.02	604.13	604.13	601.96	601.58
Machinery	812.45	806.49	789.71	777.35	754.25	748.98
Leasehold Improvements	-	-	-	-	-	0.43

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.